Header Logo

STEPHANIE SHERMAN

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address1504 TAUB LOOP
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Harvard College, Cambridge, MAAB05/2005History of Science
    University of Michigan Medical School, Ann Arbor, MIMD05/2011Medicine
    Massachussetts General Hospital, Boston, MA06/2014Internal Medicine Residency
    Collapse awards and honors
    2021John P. McGovern Outstanding Teacher Award - Clinical Teaching, Baylor College of Medicine
    2018 - 2021Graduating Class Teaching Award, Baylor College of Medicine
    2021Women of Excellence Award, Baylor College of Medicine
    2019Baylor Housestaff Teaching Faculty Award - VA Hospital, Baylor College of Medicine IM Residency
    2019White Coat Ceremony Speaker, Baylor College of Medicine
    2018Early Career Faculty Award for Excellence in Patient Care, Baylor College of Medicine
    2018Baylor Housestaff Teaching Faculty Award - Ben Taub Hospital, Baylor College of Medicine IM Residency
    2018Internal Medicine Core Clerkship Best Teaching Attending, Baylor College of Medicine
    2017Baylor Housestaff Teaching Faculty Award - Ben Taub Hospital, Baylor College of Medicine IM Residency
    2017Internal Medicine Core Clerkship Best Teaching Attending, Baylor College of Medicine
    2015Harris Health Hero Award, Ben Taub General Hospital

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Li Z, Yang W, Wu G, Chang TC, Cheng Z, Devidas M, Shago M, Carroll AJ, Heerema NA, Gastier-Foster JM, Wood BL, Sanclemente L, Raetz EA, Hunger SP, Loh ML, Feingold E, Rosser TC, Allen EG, Sherman SL, Rabin KR, Lupo PJ, Yang JJ. Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndrome. Nat Commun. 2025 Jul 09; 16(1):6316. PMID: 40628699; PMCID: PMC12238278.
      Citations:    Fields:    Translation:Humans
    2. Feldman ER, Li Y, Cutler DJ, Rosser TC, Wechsler SB, Sanclemente L, Rachubinski AL, Elliott N, Vyas P, Roberts I, Rabin KR, Wagner M, Gelb BD, Espinosa JM, Lupo PJ, de Smith AJ, Sherman SL, Leslie-Clarkson EJ. Genome-Wide Association Studies of Down Syndrome Associated Congenital Heart Defects Suggests a Genetically Heterogeneous Risk for CHD in DS. Genet Epidemiol. 2025 Jun; 49(4):e70010. PMID: 40407036; PMCID: PMC12278782.
      Citations:    Fields:    Translation:Humans
    3. Cardenas GE, Ren L, Sherman SV. Cortisol and Contagions: Infections in Cushing's Syndrome. Am J Med. 2025 Apr; 138(4):e58-e59. PMID: 39667517.
      Citations:    
    4. Feldman ER, Li Y, Cutler DJ, Rosser TC, Wechsler SB, Sanclemente L, Rachubinski AL, Elliott N, Vyas P, Roberts I, Rabin KR, Wagner M, Gelb BD, Espinosa JM, Lupo PJ, de Smith AJ, Sherman SL, Leslie EJ. Genome-wide association studies of Down syndrome associated congenital heart defects. medRxiv. 2024 Sep 06. PMID: 39281767; PMCID: PMC11398599.
      Citations:    
    5. Jamison T, Sargsyan Z, Ayyala U, Sherman S, Kaplan H. A Mini Chalk Talk Workshop for Fourth-Year Medical Students: Facilitating the Transition From Student to Resident Educator. MedEdPORTAL. 2024; 20:11404. PMID: 38957529; PMCID: PMC11219125.
      Citations:    Fields:    Translation:Humans
    6. Rezigh A, Rezigh A, Sherman S. Lessons in clinical reasoning?- pitfalls, myths, and pearls: a woman brought to a halt. Diagnosis (Berl). 2024 May 01; 11(2):205-211. PMID: 38329454.
      Citations:    Fields:    Translation:Humans
    7. Li Z, Chang TC, Junco JJ, Devidas M, Li Y, Yang W, Huang X, Hedges DJ, Cheng Z, Shago M, Carroll AJ, Heerema NA, Gastier-Foster J, Wood BL, Borowitz MJ, Sanclemente L, Raetz EA, Hunger SP, Feingold E, Rosser TC, Sherman SL, Loh ML, Mullighan CG, Yu J, Wu G, Lupo PJ, Rabin KR, Yang JJ. Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia. Blood. 2023 07 13; 142(2):172-184. PMID: 37001051; PMCID: PMC10352600.
      Citations: 1     Fields:    Translation:Animals
    8. Sargsyan Z, Sherman S. Upright Positioning to Maintain Quantitative Measurement of Higher Right Atrial Pressures. J Am Soc Echocardiogr. 2023 05; 36(5):565-566. PMID: 36773818.
      Citations:    Fields:    Translation:Humans
    9. Harrison D, Pahwa A, Muradali K, Misra A, Sherman S. Things We Do for No Reason?: Routinely obtaining repeat transthoracic echocardiography for acute decompensation of known chronic heart failure. J Hosp Med. 2023 10; 18(10):934-937. PMID: 36739110.
      Citations:    Fields:    
    10. Rendon DR, Shiau J, Sherman SV. Lobar Pneumonia Presenting as Fever, Headaches, and a Negative Chest Radiograph. Am J Med. 2023 04; 136(4):e65-e66. PMID: 36649839.
      Citations: 1     Fields:    Translation:Humans
    11. Poteet B, Ali N, Bellcross C, Sherman SL, Espinel W, Hipp H, Allen EG. The diagnostic experience of women with fragile X-associated primary ovarian insufficiency (FXPOI). J Assist Reprod Genet. 2023 Jan; 40(1):179-190. PMID: 36447079; PMCID: PMC9840735.
      Citations:    Fields:    
    12. Rezigh AB, Rezigh A, Kanjee Z, Sargsyan Z, Sherman S, Kumfer AM. Outside looking in. J Hosp Med. 2023 07; 18(7):633-637. PMID: 36451344.
      Citations:    Fields:    
    13. Kusnoor AV, Balchandani R, Pillow MT, Sherman S, Ismail N. Near-peers effectively teach clinical documentation skills to early medical students. BMC Med Educ. 2022 Oct 08; 22(1):712. PMID: 36209076; PMCID: PMC9548193.
      Citations:    Fields:    Translation:Humans
    14. Pinku H, H?ls A, Feany PT, Baumer N, Dierssen M, Bargagna S, Costa AC, Chicoine BA, Rebillat AS, Sgandurra G, Valentini D, Rohrer RT, Levin J, Lakhanpaul M, Carf? A, Sherman SL, Strydom A, Ghosh S, Trisomy 21 Research Society COVID-19 Initiative Study Group. Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey. J Glob Health. 2022 Aug 08; 12:05035. PMID: 35932238; PMCID: PMC9356581.
      Citations:    
    15. Albizua I, Charen K, Shubeck L, Talboy A, Berry-Kravis E, Kaufmann WE, Stallworth JL, Drazba KT, Erickson CA, Sweeney JA, Tartaglia N, Warren SF, Hagerman R, Sherman SL, Warren ST, Jin P, Allen EG. Descriptive analysis of seizures and comorbidities associated with fragile X syndrome. Mol Genet Genomic Med. 2022 08; 10(8):e2001. PMID: 35852003; PMCID: PMC9356544.
      Citations:    
    16. Hessl D, Rosselot H, Miller R, Espinal G, Famula J, Sherman SL, Todd PK, Cabal Herrera AM, Lipworth K, Cohen J, Hall DA, Leehey M, Grigsby J, Weber JD, Alusi S, Wheeler A, Raspa M, Hudson T, Sobrian SK. The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness. J Med Genet. 2022 12; 59(12):1165-1170. PMID: 35701103; PMCID: PMC9691813.
      Citations:    
    17. Kong HE, Lim J, Linsalata A, Kang Y, Malik I, Allen EG, Cao Y, Shubeck L, Johnston R, Huang Y, Gu Y, Guo X, Zwick ME, Qin Z, Wingo TS, Juncos J, Nelson DL, Epstein MP, Cutler DJ, Todd PK, Sherman SL, Warren ST, Jin P. Identification of PSMB5 as a genetic modifier of fragile X-associated tremor/ataxia syndrome. Proc Natl Acad Sci U S A. 2022 05 31; 119(22):e2118124119. PMID: 35617426; PMCID: PMC9295734.
      Citations:    Fields:    Translation:HumansAnimals
    18. Thapi S, Tsega S, Zhao C, Olson APJ, Sherman SV. Dyspneic and dizzy. J Hosp Med. 2022 08; 17(8):657-660. PMID: 35535933.
      Citations:    
    19. H?ls A, Feany PT, Zisman SI, Costa ACS, Dierssen M, Balogh R, Bargagna S, Baumer NT, Brand?o AC, Carfi A, Chicoine BA, Ghosh S, Lakhanpaul M, Levin J, Lunsky Y, Manso C, Okun E, Real de Asua D, Rebillat AS, Rohrer TR, Sgandurra G, Valentini D, Sherman SL, Strydom A. COVID-19 Vaccination of Individuals with Down Syndrome-Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated. Vaccines (Basel). 2022 Mar 29; 10(4). PMID: 35455279; PMCID: PMC9030605.
      Citations:    
    20. Phadke VK, Jagannath AD, Patel AA, Sherman SV. Over the Threshold: an Exercise in Clinical Reasoning. J Gen Intern Med. 2022 04; 37(5):1290-1294. PMID: 35075534; PMCID: PMC8971242.
      Citations:    
    21. Stallings EB, Isenburg JL, Heinke D, Sherman SL, Kirby RS, Lupo PJ, National Birth Defects Prevention Network. Co-occurrence of congenital anomalies by maternal race/ethnicity among infants and fetuses with Down syndrome, 2013-2017: A U.S. population-based analysis. Birth Defects Res. 2022 01 15; 114(2):57-61. PMID: 34951159; PMCID: PMC8916111.
      Citations:    Fields:    Translation:Humans
    22. Emes D, H?ls A, Baumer N, Dierssen M, Puri S, Russell L, Sherman SL, Strydom A, Bargagna S, Brand?o AC, Costa ACS, Feany PT, Chicoine BA, Ghosh S, Rebillat AS, Sgandurra G, Valentini D, Rohrer TR, Levin J, Lakhanpaul M. COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey. J Clin Med. 2021 Oct 31; 10(21). PMID: 34768645; PMCID: PMC8584980.
      Citations:    
    23. Allen EG, Charen K, Hipp HS, Shubeck L, Amin A, He W, Hunter JE, Shelly KE, Sherman SL. Predictors of Comorbid Conditions in Women Who Carry an FMR1 Premutation. Front Psychiatry. 2021; 12:715922. PMID: 34658954; PMCID: PMC8517131.
      Citations:    
    24. Dimachkie Nunnally A, Nguyen V, Anglo C, Sterling A, Edgin J, Sherman S, Berry-Kravis E, Del Hoyo Soriano L, Abbeduto L, Thurman AJ. Symptoms of Autism Spectrum Disorder in Individuals with Down Syndrome. Brain Sci. 2021 Sep 26; 11(10). PMID: 34679343; PMCID: PMC8533848.
      Citations:    
    25. Real de Asua D, Mayer MA, Ortega MDC, Borrel JM, Bermejo TJ, Gonz?lez-Lamu?o D, Manso C, Moldenhauer F, Carmona-Iragui M, H?ls A, Sherman SL, Strydom A, de la Torre R, Dierssen M. Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome. J Clin Med. 2021 Aug 23; 10(16). PMID: 34442043; PMCID: PMC8397064.
      Citations:    
    26. Trevino CE, Holleman AM, Corbitt H, Maslen CL, Rosser TC, Cutler DJ, Johnston HR, Rambo-Martin BL, Oberoi J, Dooley KJ, Capone GT, Reeves RH, Cordell HJ, Keavney BD, Agopian AJ, Goldmuntz E, Gruber PJ, O'Brien JE, Bittel DC, Wadhwa L, Cua CL, Moskowitz IP, Mulle JG, Epstein MP, Sherman SL, Zwick ME. Author Correction: Identifying genetic factors that contribute to the increased risk of congenital heart defects in infants with Down syndrome. Sci Rep. 2021 Jul 20; 11(1):15164. PMID: 34285246; PMCID: PMC8292424.
      Citations:    Fields:    
    27. Del Hoyo Soriano L, Rosser TC, Hamilton DR, Harvey DJ, Abbeduto L, Sherman SL. Relationship between Apgar scores and long-term cognitive outcomes in individuals with Down syndrome. Sci Rep. 2021 06 16; 11(1):12707. PMID: 34135349; PMCID: PMC8208985.
      Citations:    
    28. Dierssen M, Herault Y, Helguera P, Mart?nez de Lagran M, Vazquez A, Christian B, Carmona-Iragui M, Wiseman F, Mobley W, Fisher EMC, Brault V, Esbensen A, Jacola LM, Potier MC, Hamlett ED, Abbeduto L, Del Hoyo Soriano L, Busciglio J, Iulita MF, Crispino J, Malinge S, Barone E, Perluigi M, Costanzo F, Delabar JM, Bartesaghi R, Dekker AD, De Deyn P, Fortea Ormaechea J, Shaw PA, Haydar TF, Sherman SL, Strydom A, Bhattacharyya A. Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society. Mol Syndromol. 2021 Jul; 12(4):202-218. PMID: 34421499; PMCID: PMC8339505.
      Citations:    
    29. Trevino CE, Rounds JC, Charen K, Shubeck L, Hipp HS, Spencer JB, Johnston HR, Cutler DJ, Zwick ME, Epstein MP, Murray A, Macpherson JN, Mila M, Rodriguez-Revenga L, Berry-Kravis E, Hall DA, Leehey MA, Liu Y, Welt C, Warren ST, Sherman SL, Jin P, Allen EG. Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation. Fertil Steril. 2021 09; 116(3):843-854. PMID: 34016428; PMCID: PMC8494118.
      Citations:    
    30. Allen EG, Charen K, Hipp HS, Shubeck L, Amin A, He W, Nolin SL, Glicksman A, Tortora N, McKinnon B, Shelly KE, Sherman SL. Refining the risk for fragile X-associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size. Genet Med. 2021 09; 23(9):1648-1655. PMID: 33927378; PMCID: PMC8460441.
      Citations:    
    31. Channell MM, Mattie LJ, Hamilton DR, Capone GT, Mahone EM, Sherman SL, Rosser TC, Reeves RH, Kalb LG, Down Syndrome Cognition Project. Capturing cognitive and behavioral variability among individuals with Down syndrome: a latent profile analysis. J Neurodev Disord. 2021 04 19; 13(1):16. PMID: 33874886; PMCID: PMC8056665.
      Citations:    
    32. Hendrix JA, Amon A, Abbeduto L, Agiovlasitis S, Alsaied T, Anderson HA, Bain LJ, Baumer N, Bhattacharyya A, Bogunovic D, Botteron KN, Capone G, Chandan P, Chase I, Chicoine B, Cieuta-Walti C, DeRuisseau LR, Durand S, Esbensen A, Fortea J, Gim?nez S, Granholm AC, Hahn LJ, Head E, Hillerstrom H, Jacola LM, Janicki MP, Jasien JM, Kamer AR, Kent RD, Khor B, Lawrence JB, Lemonnier C, Lewanda AF, Mobley W, Moore PE, Nelson LP, Oreskovic NM, Osorio RS, Patterson D, Rasmussen SA, Reeves RH, Roizen N, Santoro S, Sherman SL, Talib N, Tapia IE, Walsh KM, Warren SF, White AN, Wong GW, Yi JS. Opportunities, barriers, and recommendations in down syndrome research. Transl Sci Rare Dis. 2021; 5(3-4):99-129. PMID: 34268067; PMCID: PMC8279178.
      Citations:    
    33. Thurman AJ, Edgin JO, Sherman SL, Sterling A, McDuffie A, Berry-Kravis E, Hamilton D, Abbeduto L. Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling. J Neurodev Disord. 2021 04 08; 13(1):13. PMID: 33827417; PMCID: PMC8028777.
      Citations:    
    34. Walsh MB, Charen K, Shubeck L, McConkie-Rosell A, Ali N, Bellcross C, Sherman SL. Men with an FMR1 premutation and their health education needs. J Genet Couns. 2021 08; 30(4):1156-1167. PMID: 33788978; PMCID: PMC8363520.
      Citations:    
    35. H?ls A, Costa ACS, Dierssen M, Baksh RA, Bargagna S, Baumer NT, Brand?o AC, Carfi A, Carmona-Iragui M, Chicoine BA, Ghosh S, Lakhanpaul M, Manso C, Mayer MA, Ortega MDC, de Asua DR, Rebillat AS, Russell LA, Sgandurra G, Valentini D, Sherman SL, Strydom A, T21RS COVID-19 Initiative. Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey. EClinicalMedicine. 2021 Mar; 33:100769. PMID: 33644721; PMCID: PMC7897934.
      Citations:    
    36. Del Hoyo Soriano L, Rosser T, Hamilton D, Wood T, Abbeduto L, Sherman S. Gestational age is related to symptoms of attention-deficit/hyperactivity disorder in late-preterm to full-term children and adolescents with down syndrome. Sci Rep. 2020 11 23; 10(1):20345. PMID: 33230240; PMCID: PMC7683733.
      Citations:    
    37. Trevino CE, Holleman AM, Corbitt H, Maslen CL, Rosser TC, Cutler DJ, Johnston HR, Rambo-Martin BL, Oberoi J, Dooley KJ, Capone GT, Reeves RH, Cordell HJ, Keavney BD, Agopian AJ, Goldmuntz E, Gruber PJ, O'Brien JE, Bittel DC, Wadhwa L, Cua CL, Moskowitz IP, Mulle JG, Epstein MP, Sherman SL, Zwick ME. Identifying genetic factors that contribute to the increased risk of congenital heart defects in infants with Down syndrome. Sci Rep. 2020 10 22; 10(1):18051. PMID: 33093519; PMCID: PMC7582922.
      Citations: 4     Fields:    Translation:Humans
    38. Oakman N, Lim J, Bui C, Kaplan H, Sherman S. When patients die: patient memorials and group reflection in an internal medicine residency program. Proc (Bayl Univ Med Cent). 2020 Sep 28; 34(1):56-58. PMID: 33456146; PMCID: PMC7785196.
      Citations:    
    39. Guo Z, Cui Y, Shi X, Birchler JA, Albizua I, Sherman SL, Qin ZS, Ji T. An empirical bayesian approach for testing gene expression fold change and its application in detecting global dosage effects. NAR Genom Bioinform. 2020 Sep; 2(3):lqaa072. PMID: 33575620; PMCID: PMC7671412.
      Citations:    
    40. Sherman S, Kumar S, Lim J, Sargsyan Z, Ratan B, Turner T. Measuring teacher identity during the transition from medical school to residency. Proc (Bayl Univ Med Cent). 2020 Jul 23; 33(4):566-571. PMID: 33100530; PMCID: PMC7549982.
      Citations:    
    41. Albizua I, Chopra P, Allen EG, He W, Amin AS, Sherman SL. Study of telomere length in men who carry a fragile X premutation or full mutation allele. Hum Genet. 2020 Dec; 139(12):1531-1539. PMID: 32533363; PMCID: PMC8494119.
      Citations:    
    42. Abbeduto L, Berry-Kravis E, Sterling A, Sherman S, Edgin JO, McDuffie A, Hoffmann A, Hamilton D, Nelson M, Aschkenasy J, Thurman AJ. Correction to: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity. J Neurodev Disord. 2020 04 02; 12(1):11. PMID: 32241250; PMCID: PMC7119274.
      Citations:    
    43. Abbeduto L, Berry-Kravis E, Sterling A, Sherman S, Edgin JO, McDuffie A, Hoffmann A, Hamilton D, Nelson M, Aschkenasy J, Thurman AJ. Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity. J Neurodev Disord. 2020 03 24; 12(1):10. PMID: 32204695; PMCID: PMC7092603.
      Citations:    
    44. Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, Sherman SL, Reeves RH. Down syndrome. Nat Rev Dis Primers. 2020 02 06; 6(1):9. PMID: 32029743; PMCID: PMC8428796.
      Citations:    
    45. Albizua I, Chopra P, Sherman SL, Gambello MJ, Warren ST. Analysis of the genomic expression profile in trisomy 18: insight into possible genes involved in the associated phenotypes. Hum Mol Genet. 2020 01 15; 29(2):238-247. PMID: 31813999.
      Citations:    
    46. Allen EG, Charen K, Hipp HS, Shubeck L, Amin A, He W, Hunter JE, Sherman SL. Clustering of comorbid conditions among women who carry an FMR1 premutation. Genet Med. 2020 04; 22(4):758-766. PMID: 31896764; PMCID: PMC7118023.
      Citations:    
    47. Keen C, Hunter JE, Allen EG, Rocheleau C, Waters M, Sherman SL. The association between maternal occupation and down syndrome: A report from the national Down syndrome project. Int J Hyg Environ Health. 2020 01; 223(1):207-213. PMID: 31519426.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    48. Channell MM, Hahn LJ, Rosser TC, Hamilton D, Frank-Crawford MA, Capone GT, Sherman SL, Down Syndrome Cognition Project. Characteristics Associated with Autism Spectrum Disorder Risk in Individuals with Down Syndrome. J Autism Dev Disord. 2019 Sep; 49(9):3543-3556. PMID: 31124029.
      Citations:    
    49. Gilbertson KE, Jackson HL, Dziuban EJ, Sherman SL, Berry-Kravis EM, Erickson CA, Valdez R. Preventive care services and health behaviors in children with fragile X syndrome. Disabil Health J. 2019 10; 12(4):564-573. PMID: 31118158; PMCID: PMC6778488.
      Citations:    
    50. Hunter JE, Jenkins CL, Grim V, Leung S, Charen KH, Hamilton DR, Allen EG, Sherman SL. Feasibility of an app-based mindfulness intervention among women with an FMR1 premutation experiencing maternal stress. Res Dev Disabil. 2019 Jun; 89:76-82. PMID: 30959430.
      Citations:    
    51. Fink DA, Nelson LM, Pyeritz R, Johnson J, Sherman SL, Cohen Y, Elizur SE. Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review. Front Genet. 2018; 9:529. PMID: 30542367; PMCID: PMC6278244.
      Citations:    
    52. Allen EG, Glicksman A, Tortora N, Charen K, He W, Amin A, Hipp H, Shubeck L, Nolin SL, Sherman SL. FXPOI: Pattern of AGG Interruptions Does not Show an Association With Age at Amenorrhea Among Women With a Premutation. Front Genet. 2018; 9:292. PMID: 30123240; PMCID: PMC6086008.
      Citations:    
    53. Sherman SL, Rao DC, Keats BJ, Yee S, Spence MA, Hassold TJ, Chakravarti A, Elston RC, Crolla JA, Ennis S, Risch N. Newton E. Morton (1929-2018). Am J Hum Genet. 2018 Jun 07; 102(6):1011-1017. PMID: 33220219; PMCID: PMC8175862.
      Citations:    
    54. Rambo-Martin BL, Mulle JG, Cutler DJ, Bean LJH, Rosser TC, Dooley KJ, Cua C, Capone G, Maslen CL, Reeves RH, Sherman SL, Zwick ME. Analysis of Copy Number Variants on Chromosome 21 in Down Syndrome-Associated Congenital Heart Defects. G3 (Bethesda). 2018 01 04; 8(1):105-111. PMID: 29141989; PMCID: PMC5765339.
      Citations: 3     Fields:    Translation:HumansCells
    55. Fischer ST, Lili LN, Li S, Tran VT, Stewart KB, Schwartz CE, Jones DP, Sherman SL, Fridovich-Keil JL. Low-level maternal exposure to nicotine associates with significant metabolic perturbations in second-trimester amniotic fluid. Environ Int. 2017 10; 107:227-234. PMID: 28759762; PMCID: PMC5569895.
      Citations:    
    56. Sherman SL, Kidd SA, Riley C, Berry-Kravis E, Andrews HF, Miller RM, Lincoln S, Swanson M, Kaufmann WE, Brown WT. FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome. Pediatrics. 2017 Jun; 139(Suppl 3):S183-S193. PMID: 28814539; PMCID: PMC5621599.
      Citations:    
    57. Kaufmann WE, Kidd SA, Andrews HF, Budimirovic DB, Esler A, Haas-Givler B, Stackhouse T, Riley C, Peacock G, Sherman SL, Brown WT, Berry-Kravis E. Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment. Pediatrics. 2017 Jun; 139(Suppl 3):S194-S206. PMID: 28814540; PMCID: PMC5619699.
      Citations:    
    58. Reines V, Charen K, Rosser T, Eisen A, Sherman SL, Visootsak J. Parental Perspectives on Pharmacological Clinical Trials: a Qualitative Study in Down Syndrome and Fragile X Syndrome. J Genet Couns. 2017 Dec; 26(6):1333-1340. PMID: 28536925.
      Citations:    
    59. . Cases from Baylor College of Medicine. ACP Hospitalist. 2017. View Publication.
    60. Begum F, Chowdhury R, Cheung VG, Sherman SL, Feingold E. Genome-Wide Association Study of Meiotic Recombination Phenotypes. G3 (Bethesda). 2016 12 07; 6(12):3995-4007. PMID: 27733454; PMCID: PMC5144969.
      Citations: 1     Fields:    Translation:HumansCells
    61. Oliver TR, Middlebrooks C, Harden A, Scott N, Johnson B, Jones J, Walker C, Wilkerson C, Saffold SH, Akinseye A, Smith T, Feingold E, Sherman SL. Variation in the Zinc Finger of PRDM9 is Associated with the Absence of Recombination along Nondisjoined Chromosomes 21 of Maternal Origin. J Down Syndr Chromosom Abnorm. 2016 Dec; 2(2). PMID: 28702511; PMCID: PMC5502783.
      Citations:    
    62. Visootsak J, Kidd SA, Anderson T, Bassell JL, Sherman SL, Berry-Kravis EM. Importance of a specialty clinic for individuals with fragile X syndrome. Am J Med Genet A. 2016 12; 170(12):3144-3149. PMID: 27649377.
      Citations:    
    63. Liu JA, Hagerman RJ, Miller RM, Craft LT, Finucane B, Tartaglia N, Berry-Kravis EM, Sherman SL, Kidd SA, Cohen J. Clinicians' experiences with the fragile X clinical and research consortium. Am J Med Genet A. 2016 12; 170(12):3138-3143. PMID: 27604509.
      Citations:    
    64. Hipp HS, Charen KH, Spencer JB, Allen EG, Sherman SL. Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI). Menopause. 2016 09; 23(9):993-9. PMID: 27552334; PMCID: PMC4998843.
      Citations:    
    65. SHERMAN S. In: Miller C, ed. Clinical Decision Support: Hospital Medicine. Decision Support in Medicine. Cerebellar Degeneration. 2016. View Publication.
    66. SHERMAN S. In: Miller C, ed. Clinical Decision Support: Hospital Medicine. Decision Support in Medicine. Eosinophilic Pneumonia. 2016. View Publication.
    67. Begum F, Sharker MH, Sherman SL, Tseng GC, Feingold E. Regionally Smoothed Meta-Analysis Methods for GWAS Datasets. Genet Epidemiol. 2016 Feb; 40(2):154-60. PMID: 26707090; PMCID: PMC4724289.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    68. Ramachandran D, Zeng Z, Locke AE, Mulle JG, Bean LJ, Rosser TC, Dooley KJ, Cua CL, Capone GT, Reeves RH, Maslen CL, Cutler DJ, Feingold E, Sherman SL, Zwick ME. Genome-Wide Association Study of Down Syndrome-Associated Atrioventricular Septal Defects. G3 (Bethesda). 2015 Jul 20; 5(10):1961-71. PMID: 26194203; PMCID: PMC4592978.
      Citations: 10     Fields:    Translation:HumansCells
    69. Espinel W, Charen K, Huddleston L, Visootsak J, Sherman S. Improving Health Education for Women Who Carry an FMR1 Premutation. J Genet Couns. 2016 Apr; 25(2):228-38. PMID: 26174939; PMCID: PMC4831205.
      Citations:    
    70. . Cases from Massachusetts General Hospital. ACP Hospitalist. 2015. View Publication.
    71. Ramachandran D, Mulle JG, Locke AE, Bean LJ, Rosser TC, Bose P, Dooley KJ, Cua CL, Capone GT, Reeves RH, Maslen CL, Cutler DJ, Sherman SL, Zwick ME. Contribution of copy-number variation to Down syndrome-associated atrioventricular septal defects. Genet Med. 2015 Jul; 17(7):554-60. PMID: 25341113; PMCID: PMC4408203.
      Citations: 8     Fields:    Translation:Humans
    72. Ruiz A, Hern?ndez I, Ronsende-Roca M, Gonz?lez-P?rez A, Rodriguez-Noriega E, Ram?rez-Lorca R, Maule?n A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gay?n J, Becker JT, Real LM, T?rraga L, Ballard C, Terrin M, Sherman S, Payami H, L?pez OL, Mintzer JE, Boada M. Erratum to "Exploratory analysis of seven Alzheimer's disease genes: disease progression" [Neurobiol. Aging 34 (2013) 1310.e1-1310.e7]. Neurobiol Aging. 2014 Nov; 35(11):2661. PMID: 28911722.
      Citations:    
    73. Sherman SL, Curnow EC, Easley CA, Jin P, Hukema RK, Tejada MI, Willemsen R, Usdin K. Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI). J Neurodev Disord. 2014; 6(1):26. PMID: 25147583; PMCID: PMC4139715.
      Citations:    
    74. Allen EG, Grus WE, Narayan S, Espinel W, Sherman SL. Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study. Front Genet. 2014; 5:260. PMID: 25147555; PMCID: PMC4124461.
      Citations:    
    75. Wheeler AC, Bailey DB, Berry-Kravis E, Greenberg J, Losh M, Mailick M, Mil? M, Olichney JM, Rodriguez-Revenga L, Sherman S, Smith L, Summers S, Yang JC, Hagerman R. Associated features in females with an FMR1 premutation. J Neurodev Disord. 2014; 6(1):30. PMID: 25097672; PMCID: PMC4121434.
      Citations:    
    76. Grigsby J, Cornish K, Hocking D, Kraan C, Olichney JM, Rivera SM, Schneider A, Sherman S, Wang JY, Yang JC. The cognitive neuropsychological phenotype of carriers of the FMR1 premutation. J Neurodev Disord. 2014; 6(1):28. PMID: 25136377; PMCID: PMC4135346.
      Citations:    
    77. Oliver TR, Middlebrooks CD, Tinker SW, Allen EG, Bean LJ, Begum F, Feingold E, Chowdhury R, Cheung V, Sherman SL. An examination of the relationship between hotspots and recombination associated with chromosome 21 nondisjunction. PLoS One. 2014; 9(6):e99560. PMID: 24926858; PMCID: PMC4057233.
      Citations: 7     Fields:    Translation:HumansCells
    78. SHERMAN S, Chong C. In: Kiefer MM, Chong CR, eds. Pocket Primary Care: A Massachusetts General Hospital Handbook. Anemia. 2014.
    79. Middlebrooks CD, Mukhopadhyay N, Tinker SW, Allen EG, Bean LJ, Begum F, Chowdhury R, Cheung V, Doheny K, Adams M, Feingold E, Sherman SL. Evidence for dysregulation of genome-wide recombination in oocytes with nondisjoined chromosomes 21. Hum Mol Genet. 2014 Jan 15; 23(2):408-17. PMID: 24014426; PMCID: PMC3869361.
      Citations: 5     Fields:    Translation:HumansCells
    80. Hunter JE, Allen EG, Shin M, Bean LJ, Correa A, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Freeman SB, Sherman SL. The association of low socioeconomic status and the risk of having a child with Down syndrome: a report from the National Down Syndrome Project. Genet Med. 2013 Sep; 15(9):698-705. PMID: 23558253; PMCID: PMC4122862.
      Citations: 2     Fields:    Translation:HumansCells
    81. Hollis ND, Allen EG, Oliver TR, Tinker SW, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Freeman SB, Sherman SL, Bean LJ. Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: a report from the National Down Syndrome Project. Am J Med Genet A. 2013 Mar; 161A(3):438-44. PMID: 23401135; PMCID: PMC3607196.
      Citations:    
    82. Juncos JL, Lazarus JT, Rohr J, Allen EG, Shubeck L, Hamilton D, Novak G, Sherman SL. Olfactory dysfunction in fragile X tremor ataxia syndrome. Mov Disord. 2012 Oct; 27(12):1556-9. PMID: 23079771; PMCID: PMC3696490.
      Citations:    
    83. Hunter JE, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Abramowitz A, Epstein MP, Lori A, Binder E, Cubells JF, Sherman SL. Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet B Neuropsychiatr Genet. 2012 Jul; 159B(5):549-59. PMID: 22573456; PMCID: PMC3696495.
      Citations:    
    84. Hunter JE, Sherman S, Grigsby J, Kogan C, Cornish K. Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts. Neuropsychology. 2012 Mar; 26(2):156-64. PMID: 22251309; PMCID: PMC3295926.
      Citations:    
    85. Oliver TR, Tinker SW, Allen EG, Hollis N, Locke AE, Bean LJ, Chowdhury R, Begum F, Marazita M, Cheung V, Feingold E, Sherman SL. Altered patterns of multiple recombinant events are associated with nondisjunction of chromosome 21. Hum Genet. 2012 Jul; 131(7):1039-46. PMID: 22160426; PMCID: PMC3925977.
      Citations: 15     Fields:    Translation:HumansCells
    86. Visootsak J, Charen K, Rohr J, Allen E, Sherman S. Diagnosis of fragile X syndrome: a qualitative study of African American families. J Genet Couns. 2012 Dec; 21(6):845-53. PMID: 22134579; PMCID: PMC3508319.
      Citations:    
    87. Hunter JE, Epstein MP, Tinker SW, Abramowitz A, Sherman SL. The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance. Behav Genet. 2012 May; 42(3):415-22. PMID: 22101959; PMCID: PMC3696489.
      Citations:    
    88. Juncos JL, Lazarus JT, Graves-Allen E, Shubeck L, Rusin M, Novak G, Hamilton D, Rohr J, Sherman SL. New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS). Neurogenetics. 2011 May; 12(2):123-35. PMID: 21279400; PMCID: PMC3766636.
      Citations:    
    89. Locke AE, Dooley KJ, Tinker SW, Cheong SY, Feingold E, Allen EG, Freeman SB, Torfs CP, Cua CL, Epstein MP, Wu MC, Lin X, Capone G, Sherman SL, Bean LJ. Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome. Genet Epidemiol. 2010 Sep; 34(6):613-23. PMID: 20718043; PMCID: PMC3378053.
      Citations: 30     Fields:    Translation:HumansCells
    90. Peprah EK, Allen EG, Williams SM, Woodard LM, Sherman SL. Genetic diversity of the fragile X syndrome gene (FMR1) in a large Sub-Saharan West African population. Ann Hum Genet. 2010 Jul; 74(4):316-25. PMID: 20597902; PMCID: PMC4149914.
      Citations:    
    91. Peprah E, He W, Allen E, Oliver T, Boyne A, Sherman SL. Examination of FMR1 transcript and protein levels among 74 premutation carriers. J Hum Genet. 2010 Jan; 55(1):66-8. PMID: 19927162; PMCID: PMC4122982.
      Citations:    
    92. Epstein MP, Hunter JE, Allen EG, Sherman SL, Lin X, Boehnke M. A Variance-Component Framework for Pedigree Analysis of Continuous and Categorical Outcomes. Stat Biosci. 2009 Nov; 1(2):181-198. PMID: 20436936; PMCID: PMC2860148.
      Citations:    
    93. Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, Warren ST. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet. 2009 Oct; 85(4):503-14. PMID: 19804849; PMCID: PMC2756550.
      Citations: 127     Fields:    Translation:HumansCellsPHPublic Health
    94. Oliver TR, Bhise A, Feingold E, Tinker S, Masse N, Sherman SL. Investigation of factors associated with paternal nondisjunction of chromosome 21. Am J Med Genet A. 2009 Aug; 149A(8):1685-90. PMID: 19606484; PMCID: PMC4111419.
      Citations:    
    95. Arnold S, Pelet A, Amiel J, Borrego S, Hofstra R, Tam P, Ceccherini I, Lyonnet S, Sherman S, Chakravarti A. Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung disease association. Hum Mutat. 2009 May; 30(5):771-5. PMID: 19306335; PMCID: PMC2779545.
      Citations: 19     Fields:    Translation:HumansCells
    96. Hunter JE, Abramowitz A, Rusin M, Sherman SL. Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature. Genet Med. 2009 Feb; 11(2):79-89. PMID: 19265746; PMCID: PMC2652667.
      Citations:    
    97. Allen EG, Freeman SB, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Sherman SL. Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects. Hum Genet. 2009 Feb; 125(1):41-52. PMID: 19050929; PMCID: PMC2833410.
      Citations: 31     Fields:    Translation:Humans
    98. Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Sherman SL. No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50. Am J Hum Genet. 2008 Dec; 83(6):692-702. PMID: 19026394; PMCID: PMC2668066.
      Citations: 37     Fields:    Translation:HumansCells
    99. Hunter JE, Epstein MP, Tinker SW, Charen KH, Sherman SL. Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity. Genet Epidemiol. 2008 Sep; 32(6):553-9. PMID: 18357616; PMCID: PMC2881575.
      Citations: 15     Fields:    Translation:HumansCells
    100. Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Sherman SL. Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behav Genet. 2008 Sep; 38(5):493-502. PMID: 18535897; PMCID: PMC3696488.
      Citations:    
    101. De Caro JJ, Dominguez C, Sherman SL. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency. Ann N Y Acad Sci. 2008; 1135:99-111. PMID: 18574214.
      Citations:    
    102. Anido A, Carlson LM, Sherman SL. Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. J Genet Couns. 2007 Feb; 16(1):97-104. PMID: 17295053.
      Citations:    
    103. Freeman SB, Allen EG, Oxford-Wright CL, Tinker SW, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Sherman SL. The National Down Syndrome Project: design and implementation. Public Health Rep. 2007 Jan-Feb; 122(1):62-72. PMID: 17236610; PMCID: PMC1802119.
      Citations: 27     Fields:    Translation:HumansCells
    104. Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev. 2007; 13(3):221-7. PMID: 17910090.
      Citations: 71     Fields:    Translation:HumansAnimalsCells
    105. Anido A, Carlson LM, Taft L, Sherman SL. Women's attitudes toward testing for fragile X carrier status: a qualitative analysis. J Genet Couns. 2005 Aug; 14(4):295-306. PMID: 16047092.
      Citations:    
    106. Allen EG, Sherman S, Abramowitz A, Leslie M, Novak G, Rusin M, Scott E, Letz R. Examination of the effect of the polymorphic CGG repeat in the FMR1 gene on cognitive performance. Behav Genet. 2005 Jul; 35(4):435-45. PMID: 15971024.
      Citations:    
    107. Small CM, Marcus M, Sherman SL, Sullivan AK, Manatunga AK, Feigelson HS. CYP17 genotype predicts serum hormone levels among pre-menopausal women. Hum Reprod. 2005 Aug; 20(8):2162-7. PMID: 15878919.
      Citations:    
    108. Lamb NE, Yu K, Shaffer J, Feingold E, Sherman SL. Association between maternal age and meiotic recombination for trisomy 21. Am J Hum Genet. 2005 Jan; 76(1):91-9. PMID: 15551222; PMCID: PMC1196437.
      Citations: 27     Fields:    Translation:HumansCells
    109. Kerstann KF, Feingold E, Freeman SB, Bean LJ, Pyatt R, Tinker S, Jewel AH, Capone G, Sherman SL. Linkage disequilibrium mapping in trisomic populations: analytical approaches and an application to congenital heart defects in Down syndrome. Genet Epidemiol. 2004 Nov; 27(3):240-51. PMID: 15389927.
      Citations: 8     Fields:    Translation:Humans
    110. Allen EG, He W, Yadav-Shah M, Sherman SL. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet. 2004 Apr; 114(5):439-47. PMID: 14758538.
      Citations: 67     Fields:    Translation:HumansCells
    111. Hertzberg VS, Stern BJ, Sherman S. Analytic strategies for stroke genetics. J Stroke Cerebrovasc Dis. 2002 Sep-Oct; 11(5):272-8. PMID: 17903885.
      Citations:    
    112. Crawford DC, Meadows KL, Newman JL, Taft LF, Scott E, Leslie M, Shubek L, Holmgreen P, Yeargin-Allsopp M, Boyle C, Sherman SL. Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet. 2002 Jul 01; 110(3):226-33. PMID: 12116230.
      Citations: 68     Fields:    Translation:HumansCells
    113. Sullivan AK, Crawford DC, Scott EH, Leslie ML, Sherman SL. Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. Am J Hum Genet. 2002 Jun; 70(6):1532-44. PMID: 11992259; PMCID: PMC379140.
      Citations: 28     Fields:    Translation:HumansCells
    SHERMAN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (316)
    Explore
    _
    Co-Authors (18)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _